Alpha Tau Medical (DRTS) Other Non-Current Liabilities (2020 - 2026)

Alpha Tau Medical (DRTS) posted Other Non-Current Liabilities of $5.4 million for Q4 2025, up 41.6% sequentially from $3.8 million in Q2 2025, and up 60.4% YoY from $3.3 million in Q4 2024.

Alpha Tau Medical (DRTS) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Alpha Tau Medical has reported Other Non-Current Liabilities for 6 years, with the latest figure at $5.4 million in Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 60.4% year-over-year to $5.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.4 million (up 60.4% YoY) and the FY2025 annual result came in at $5.4 million, up 60.4% from the prior year.
  • Other Non-Current Liabilities improved to $5.4 million in Q4 2025 per DRTS's latest filing, from $3.8 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $18.6 million in Q4 2021 and troughed at $977000.0 in Q4 2023.
  • A 5-year average of $7.1 million and a median of $4.1 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2021 and 2022: Other Non-Current Liabilities surged 247.06% in 2021, then slumped 88.04% in 2022.
  • Over 5 years, Other Non-Current Liabilities stood at $18.6 million in 2021, then plunged by 88.04% to $2.2 million in 2022, then plunged by 56.15% to $977000.0 in 2023, then surged by 241.66% to $3.3 million in 2024, then surged by 60.4% to $5.4 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $5.4 million, $3.8 million, and $3.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Alpha Tau Medical 1.32 Bn 1.32 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2026 47.54 Mn
Dec 31, 2025 5.35 Mn
Jun 30, 2025 3.78 Mn
Dec 31, 2024 3.34 Mn
Jun 30, 2024 4.06 Mn
Dec 31, 2023 977,000.00
Dec 31, 2022 2.23 Mn
Mar 31, 2022 16.91 Mn
Dec 31, 2021 18.62 Mn
Mar 31, 2021 8.46 Mn
Dec 31, 2020 5.37 Mn